Type of investor | Early stage VC Growth stage VC Late stage VC |
Typical investment size | $1M - $2.5M More than $2.5M |
Typical investments in a year | 10 |
Categories of interest | |
Locations of interest | |
Credentials | Accredited Investor |
Dr. Shubhra Jain joined Cota in 2018 as a Senior Associate where she is responsible for sourcing, executing and analyzing healthcare investments. Prior to Cota, Shubhra was Associate Director of Commercial Strategy and Corporate Development at Natera where she focused on Biopharma Partnerships, the diligence of potential acquisitions, market research and competitive positioning. Prior to Natera, she led Product management for Acute care suite of products at Pieces Technologies where she led product development and launch of SaaS risk surveillance and prediction solutions for clinical outcomes and published peer-reviewed research on the subject. Prior to Pieces, Dr. Jain served as a consultant and an advisor to several health tech startups and Fortune 500 companies.
Dr. Jain is a Primary Care Physician from India, has her Masters in Engineering from Stanford with a major in Biodesign and her MBA from the Wharton School of Business.